40 related articles for article (PubMed ID: 740580)
1. The effect of oestradiol valerate and cyclic oestradiol valerate/DL-norgestrel on calcium metabolism.
Crilly RG; Marshall DH; Nordin BE
Postgrad Med J; 1978; 54 Suppl 2():47-9. PubMed ID: 740580
[TBL] [Abstract][Full Text] [Related]
2. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
[TBL] [Abstract][Full Text] [Related]
3. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
[TBL] [Abstract][Full Text] [Related]
4. [Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation].
Davidsen PC; Secher NJ; Pedersen GT; Christensen NC
Ugeskr Laeger; 1974 Aug; 136(32):1805-8. PubMed ID: 4605940
[No Abstract] [Full Text] [Related]
5. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
6. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Vilska S; Punnonen R; Rauramo L
Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
[TBL] [Abstract][Full Text] [Related]
7. Skinfold thickness and long-term post-menopausal hormone therapy.
Punnonen R; Vilska S; Rauramo L
Maturitas; 1984 Apr; 5(4):259-62. PubMed ID: 6738372
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
[TBL] [Abstract][Full Text] [Related]
9. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
Cieraad D; Conradt C; Jesinger D; Bakowski M
Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
[TBL] [Abstract][Full Text] [Related]
10. Calcium and osteoporosis.
Nordin BE; Polley KJ; Need AG; Morris HA; Horowitz H
Ann Chir Gynaecol; 1988; 77(5-6):212-8. PubMed ID: 3076047
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women.
Wolfe BM; Huff MW
J Clin Invest; 1989 Jan; 83(1):40-5. PubMed ID: 2910918
[TBL] [Abstract][Full Text] [Related]
12. Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women.
Need AG; Morris HA; Cleghorn DB; De Nichilo D; Horowitz M; Nordin BE
Arch Intern Med; 1991 Apr; 151(4):757-9. PubMed ID: 2012460
[TBL] [Abstract][Full Text] [Related]
13. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal bone loss: does HRT always work?
Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
[TBL] [Abstract][Full Text] [Related]
15. Urinary magnesium in early postmenopausal women. Influence of hormone therapy on calcium.
Schlemmer A; Pødenphant J; Riis BJ; Christiansen C
Magnes Trace Elem; 1991-1992; 10(1):34-9. PubMed ID: 1814322
[TBL] [Abstract][Full Text] [Related]
16. Fasting urinary sodium/creatinine in relation to calcium/creatinine and hydroxyproline/creatinine in a general population of women.
Goulding A
N Z Med J; 1981 May; 93(683):294-7. PubMed ID: 6942284
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of bone-related biochemical changes at the menopause.
Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654
[TBL] [Abstract][Full Text] [Related]
18. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.
Wolfe BM; Huff MW
J Clin Invest; 1993 Jul; 92(1):456-61. PubMed ID: 8326011
[TBL] [Abstract][Full Text] [Related]
19. Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function.
Fletcher CD; Farish E; Dagen MM; Allam BF; Hart DM
Maturitas; 1988 Mar; 9(4):347-57. PubMed ID: 2837620
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacological features of oestradiol valerate.
Düsterberg B; Nishino Y
Maturitas; 1982 Dec; 4(4):315-24. PubMed ID: 7169965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
